These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16882883)

  • 41. TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.
    Tsika RW; Ma L; Kehat I; Schramm C; Simmer G; Morgan B; Fine DM; Hanft LM; McDonald KS; Molkentin JD; Krenz M; Yang S; Ji J
    J Biol Chem; 2010 Apr; 285(18):13721-35. PubMed ID: 20194497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model.
    Schips TG; Wietelmann A; Höhn K; Schimanski S; Walther P; Braun T; Wirth T; Maier HJ
    Cardiovasc Res; 2011 Sep; 91(4):587-97. PubMed ID: 21628326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading.
    Tsukamoto Y; Mano T; Sakata Y; Ohtani T; Takeda Y; Tamaki S; Omori Y; Ikeya Y; Saito Y; Ishii R; Higashimori M; Kaneko M; Miwa T; Yamamoto K; Komuro I
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1658-67. PubMed ID: 24043257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathological and physiological hypertrophies are regulated by distinct gene programs.
    Beisvag V; Kemi OJ; Arbo I; Loennechen JP; Wisløff U; Langaas M; Sandvik AK; Ellingsen Ø
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):690-7. PubMed ID: 19809332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adaptive response of the heart to long-term anemia induced by iron deficiency.
    Naito Y; Tsujino T; Matsumoto M; Sakoda T; Ohyanagi M; Masuyama T
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H585-93. PubMed ID: 19136608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. H11 kinase is a novel mediator of myocardial hypertrophy in vivo.
    Depre C; Hase M; Gaussin V; Zajac A; Wang L; Hittinger L; Ghaleh B; Yu X; Kudej RK; Wagner T; Sadoshima J; Vatner SF
    Circ Res; 2002 Nov; 91(11):1007-14. PubMed ID: 12456486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure.
    Yu P; Zhang Y; Li C; Li Y; Jiang S; Zhang X; Ding Z; Tu F; Wu J; Gao X; Li L
    J Cell Mol Med; 2015 Jul; 19(7):1710-9. PubMed ID: 25851780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B; Zeng H; Wen Z; Chen C; Wang DW
    Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of expression of contractile proteins with cardiac hypertrophy and failure.
    Martin XJ; Wynne DG; Glennon PE; Moorman AF; Boheler KR
    Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):181-9. PubMed ID: 8739245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telomere dynamics during aging in polygenic left ventricular hypertrophy.
    Marques FZ; Booth SA; Prestes PR; Curl CL; Delbridge LM; Lewandowski P; Harrap SB; Charchar FJ
    Physiol Genomics; 2016 Jan; 48(1):42-9. PubMed ID: 26508703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
    Duisters RF; Tijsen AJ; Schroen B; Leenders JJ; Lentink V; van der Made I; Herias V; van Leeuwen RE; Schellings MW; Barenbrug P; Maessen JG; Heymans S; Pinto YM; Creemers EE
    Circ Res; 2009 Jan; 104(2):170-8, 6p following 178. PubMed ID: 19096030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
    Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium regulatory proteins and their alteration by transgenic approaches.
    Dillmann WH
    Am J Cardiol; 1999 Jun; 83(12A):89H-91H. PubMed ID: 10750595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
    Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
    J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.